Lindbrook Capital’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $220K | Buy |
1,940
+1,526
| +369% | +$173K | 0.02% | 387 |
|
|
2024
Q4 | $43.7K | Sell |
414
-23
| -5% | -$2.43K | ﹤0.01% | 874 |
|
|
2024
Q3 | $47.2K | Sell |
437
-26
| -6% | -$2.81K | ﹤0.01% | 849 |
|
|
2024
Q2 | $50.2K | Sell |
463
-1,126
| -71% | -$122K | ﹤0.01% | 796 |
|
|
2024
Q1 | $210K | Buy |
1,589
+19
| +1% | +$2.51K | 0.02% | 352 |
|
|
2023
Q4 | $191K | Buy |
1,570
+344
| +28% | +$41.9K | 0.02% | 361 |
|
|
2023
Q3 | $138K | Sell |
1,226
-34
| -3% | -$3.82K | 0.02% | 397 |
|
|
2023
Q2 | $183K | Buy |
1,260
+7
| +0.6% | +$1.02K | 0.02% | 343 |
|
|
2023
Q1 | $162K | Buy |
1,253
+34
| +3% | +$4.39K | 0.02% | 363 |
|
|
2022
Q4 | $155K | Buy |
1,219
+24
| +2% | +$3.06K | 0.02% | 388 |
|
|
2022
Q3 | $125K | Sell |
1,195
-32
| -3% | -$3.35K | 0.02% | 387 |
|
|
2022
Q2 | $129K | Buy |
1,227
+48
| +4% | +$5.05K | 0.02% | 394 |
|
|
2022
Q1 | $151K | Buy |
1,179
+825
| +233% | +$106K | 0.02% | 359 |
|
|
2021
Q4 | $44K | Buy |
354
+202
| +133% | +$25.1K | 0.01% | 765 |
|
|
2021
Q3 | $22K | Sell |
152
-23
| -13% | -$3.33K | 0.01% | 717 |
|
|
2021
Q2 | $27K | Hold |
175
| – | – | 0.01% | 678 |
|
|
2021
Q1 | $27K | Buy |
175
+39
| +29% | +$6.02K | 0.01% | 642 |
|
|
2020
Q4 | $20K | Hold |
136
| – | – | ﹤0.01% | 689 |
|
|
2020
Q3 | $18K | Buy |
136
+18
| +15% | +$2.38K | 0.01% | 655 |
|
|
2020
Q2 | $14K | Sell |
118
-8
| -6% | -$949 | ﹤0.01% | 734 |
|
|
2020
Q1 | $12K | Sell |
126
-103
| -45% | -$9.81K | ﹤0.01% | 710 |
|
|
2019
Q4 | $33K | Buy |
229
+20
| +10% | +$2.88K | 0.01% | 571 |
|
|
2019
Q3 | $28K | Hold |
209
| – | – | 0.01% | 605 |
|
|
2019
Q2 | $23K | Hold |
209
| – | – | 0.01% | 651 |
|
|
2019
Q1 | $25K | Buy |
209
+141
| +207% | +$16.9K | 0.01% | 622 |
|
|
2018
Q4 | $6K | Buy |
+68
| New | +$6K | ﹤0.01% | 985 |
|